All News

Emergency Response Exercise To Be Conducted 11-15-17

November 13th, 2017 in Events, Featured, Press Releases.

FOR IMMEDIATE RELEASE: NOVEMBER 15, 2017 Contact: Colin Riley (617) 353-5386, criley@bu.edu  (Boston) – On Wednesday, November 15, between 9 a.m.- noon, Boston University (BU) will conduct an emergency response exercise at the National Emerging Infectious Diseases Laboratories (NEIDL) located at 620 Albany Street. This simulation is part of the NEIDL’s ongoing... More

Raising Ebola with Elke Muhlberger

October 24th, 2017 in Featured, In The News, Lab Updates, Video.

Original article from: STAT posted on October 20, 2017. by Hyacinth Empinado Research on dangerous pathogens like Ebola takes place inside highly secure biosafety level-4 (BSL-4) labs. Elke Mühlberger, a researcher at the National Emerging Diseases Laboratory at Boston University, takes you as close to Ebola as you’ll ever get and... More

BU Annual Giving Society Webinar: A Conversation with Dr. Ronald Corley

June 9th, 2017 in Featured, Lab Updates, Video.

The BU Annual Fund Leadership Giving Society presents a conversation with Dr. Ronald Corley, professor and chair of the microbiology at the BU School of Medicine and director of the National Emerging Infectious Diseases Laboratories (NEIDL).

After 15 years, Deadly Disease Research Lab nears Approval in Boston

May 31st, 2017 in Featured, In The News.

Original article from Boston 25 News. May 30, 2017 BOSTON - A lab to study deadly diseases like Ebola and bubonic plague is just one vote away from approval in the heart of Boston. Supporters say it will speed the development of new vaccines and cures.  But after 15 year of... More

Advances in Ebola Diagnosis and Treatment

May 23rd, 2017 in Featured, In The News.

Original article from WCAI by Heather Goldstone  May 22, 2017 Ebola is back. The virus killed more than 11,000 people between 2014 and 2016. It was the largest Ebola outbreak ever documented. Now, health officials say there’s a new outbreak in the Democratic Republic of Congo. Officials are reporting four deaths and... More

You Can’t Bomb Ebola’: How Nations Should Respond To the Next Pandemic

May 5th, 2017 in Featured, In The News.

Original article in Time Health Magazine - Alexandra Sifferlin  May 03, 2017 The Ebola outbreak of 2014 infected more than 28,000 people in West Africa and killed more than 11,000. It also exposed gaps in the world's ability to respond to epidemics of infectious diseases. Are we more prepared now to respond... More

How do We Deal with Unknown Diseases? – Dr. Dennis Carroll

April 18th, 2017 in EIDA2Z Videos, Video.

Dr Dennis Carroll is Director of the Emerging Threats Program at the U.S. Agency for International Development. We spoke to him at EIDA2Z about the current approach to tackling emerging diseases – and how we need to change it.

New Report Charts Ways to Expedite Research During Epidemics

April 13th, 2017 in Featured, In The News.

Original article from: Scientific American posted on April 12, 2017. by Helen Branswell When the largest Ebola outbreak in history exploded across West Africa in 2014, public health authorities raced to test experimental vaccines and drugs they hoped would quell the massive epidemic. But the trials process was too slow, and in... More

NEIDL Researchers Present Case for Next-Level Research

March 7th, 2017 in Events, Featured, In The News.

Original article from: BU Today posted on March 7, 2017. by Art Jahnke Infectious disease experts and administrators from Boston University told the Boston Biosafety Committee (BBC) on Monday night that the ability to conduct research at Biosafety Level 4 (BSL-4) at BU’s National Emerging Infectious Diseases Laboratory (NEIDL) would speed... More

Boston Public Health Commission to Consider NEIDL Research Request Tonight

March 6th, 2017 in Events, Featured, In The News, Lab Updates.

Original article from: BU Today posted on March 6, 2017. by Sara Rimer The Boston Public Health Commission will hold a public meeting this evening, Monday, March 6, to discuss a request by Boston University’s National Emerging Infectious Diseases Laboratories (NEIDL) for permission to conduct research at Biosafety Level 4 (BSL-4). More